Dr. Dave is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
# MC8201
San Diego, CA 92103Phone+1 800-926-8273
Education & Training
- University of California (San Diego) Medical CenterFellowship, Transplant Hepatology, 2019 - 2020
- University of California (San Diego) Medical CenterFellowship, Gastroenterology, 2017 - 2020
- University of California (San Francisco)Residency, Internal Medicine, 2014 - 2017
- University of Pittsburgh School of MedicineClass of 2014
Certifications & Licensure
- CA State Medical License 2015 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Clinical Trials
- Guselkumab (Anti-IL 23 Monoclonal Antibody) for Alcohol Associated Liver Disease Start of enrollment: 2021 Mar 03
Publications & Presentations
PubMed
- 7 citationsImpact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis.Mohammad Saeid Rezaee-Zavareh, Yee Hui Yeo, Tielong Wang, Zhiyong Guo, Parissa Tabrizian
Journal of Hepatology. 2025-01-01 - 1 citationsEditorial: Checkpoint Inhibitor-Induced Liver Injury-Time to Abandon CTCAE?Kelly Torosian, Shravan Dave
Alimentary Pharmacology & Therapeutics. 2024-12-01 - Editorial: NAFLD, NAFLD, or MASLD: what's in a name?Maryam Zafer, Shravan Dave
Alimentary Pharmacology & Therapeutics. 2024-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: